Detalles de la búsqueda
1.
Defective interfering viruses and their potential as antiviral agents.
Rev Med Virol
; 20(1): 51-62, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20041441
2.
Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG.
J Exp Med
; 161(1): 198-209, 1985 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-2981953
3.
Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization.
J Immunol Methods
; 220(1-2): 93-103, 1998 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-9839930
4.
Protection of three strains of mice against lethal influenza in vivo by defective interfering virus.
Virus Res
; 29(2): 179-83, 1993 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-8212859
5.
Postattachment neutralization of a primary strain of HIV type 1 in peripheral blood mononuclear cells is mediated by CD4-specific antibodies but not by a glycoprotein 120-specific antibody that gives potent standard neutralization.
AIDS Res Hum Retroviruses
; 17(17): 1645-54, 2001 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-11779352
6.
Production of long-lived neutralizing antibodies to HIV-1 IIIB in mice with a vaccinia recombinant virus-infected cell vaccine expressing gp160.
AIDS Res Hum Retroviruses
; 10(2): 205-12, 1994 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-8198873
7.
Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus.
AIDS Res Hum Retroviruses
; 11(3): 327-34, 1995 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-7786579
8.
Defective influenza A virus generated entirely from plasmids: its RNA is expressed in infected mouse lung and modulates disease.
J Virol Methods
; 108(1): 75-82, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12565156
9.
Determination of affinities of a panel of IgGs and Fabs for whole enveloped (influenza A) virions using surface plasmon resonance.
J Virol Methods
; 62(1): 33-42, 1996 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-8910646
10.
Neutralization titres of HIV-1-specific monoclonal antibodies vary according to the batch of primary human peripheral blood lymphocytes, but do not vary coordinately.
J Virol Methods
; 67(1): 69-76, 1997 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-9274819
11.
A rapid method for the inactivation of virus infectivity prior to assay for interferons.
J Virol Methods
; 8(4): 349-51, 1984 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-6206084
12.
Increasing the efficiency of virus infectivity assays: small inoculum volumes are as effective as centrifugal enhancement.
J Virol Methods
; 98(2): 167-9, 2001 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-11576644
13.
Inhibition of the processing of ribosomal RNA in avian cells infected with an influenza virus.
Biochim Biophys Acta
; 361(2): 198-208, 1974 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-4413897
14.
Neutralization of animal viruses.
Curr Top Microbiol Immunol
; 183: 1-149, 1993.
Artículo
en Inglés
| MEDLINE | ID: mdl-8354080
15.
Defective interfering viruses and infections of animals.
Curr Top Microbiol Immunol
; 128: 55-84, 1986.
Artículo
en Inglés
| MEDLINE | ID: mdl-3533448
16.
Neutralization of animal virus infectivity by antibody.
Arch Virol
; 152(6): 1047-59, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17516034
17.
Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection.
Vaccine
; 24(20): 4290-6, 2006 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16621180
18.
Defective interfering viruses: modulators of infection.
Microbiol Sci
; 2(1): 1-7, 1985 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-3940146
19.
Approximately 150 nucleotides from the 5' end of an influenza A segment 1 defective virion RNA are needed for genome stability during passage of defective virus in infected cells.
Virology
; 275(2): 278-85, 2000 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-10998328
20.
Two influenza A virus-specific Fabs neutralize by inhibiting virus attachment to target cells, while neutralization by their IgGs is complex and occurs simultaneously through fusion inhibition and attachment inhibition.
Virology
; 278(2): 423-35, 2000 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-11118365